Lack of Evidence for Blood Pressure Effects of Caffeine Added to Ibuprofen

Area of Science:

• Pharmacology
• Cardiovascular Science
• Pain Management

Background:

• Caffeine is known to enhance non-opioid analgesic efficacy.
• Cardiovascular effects of caffeine intake are debated, with limited research on its use in medical contexts.
• Investigating the safety of caffeine in combination with analgesics is crucial.

Purpose of the Study:

• To evaluate the cardiovascular effects of a fixed-dose ibuprofen/caffeine combination compared to ibuprofen alone.
• To assess vital signs and plasma catecholamine levels following administration of the analgesic combination.
• To determine the safety profile of caffeine when used adjunctively with ibuprofen for pain relief.

Main Methods:

• Secondary analysis of a randomized, cross-over bioequivalence study involving 36 healthy volunteers.
• Comparison of a single dose of ibuprofen/caffeine (400/100 mg) versus ibuprofen alone.
• Analysis of plasma catecholamines to understand the mechanistic basis of observed effects.

Main Results:

• Vital signs (heart rate, blood pressure) remained comparable between the ibuprofen/caffeine and ibuprofen-only groups over 24 hours.
• Plasma catecholamine levels were similar in both treatment groups.
• Exclusion of 10 participants who violated protocol by pre-dosing caffeine ensured data integrity.

Conclusions:

• Occasional intake of a low-dose caffeine (100 mg) within pain medication does not appear to pose a cardiovascular health risk based on vital sign stability.
• The combination of ibuprofen and caffeine demonstrates a favorable risk/benefit profile for occasional use, supported by enhanced efficacy.
• This study supports the use of caffeine as an adjunct to non-opioid analgesics like ibuprofen for improved pain management outcomes.